Study of Mirogabalin for Central Neuropathic Pain

NCT03901352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Neuropathic Pain

Interventions

DRUG: Placebo
DRUG: Mirogabalin

Sponsor

Daiichi Sankyo Co., Ltd.